Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2022-02-02 7:11 pm Sale | 13G | ANAPTYSBIO INC ANAB | BlackRock Inc. BLK | 1,865,288 6.8% | -42,546 (-2.23%) | View |
2021-05-11 4:08 pm Purchase | 13D | ANAPTYSBIO INC ANAB | EcoR1 Capital LLC | 7,520,424 27.5% | 368,800 (+5.16%) | View |
2021-04-12 5:45 pm Unchanged | 13D | ANAPTYSBIO INC ANAB | EcoR1 Capital LLC | 7,151,624 26.1% | 0 (Unchanged) | View |
2021-03-10 5:17 pm Purchase | 13D | ANAPTYSBIO INC ANAB | EcoR1 Capital LLC | 7,151,624 26.1% | 3,338,300 (+87.54%) | View |
2021-03-10 5:02 pm Purchase | 13D | ANAPTYSBIO INC ANAB | EcoR1 Capital Fund L.P. | 7,151,624 26.1% | 7,151,624 (New Position) | View |
2021-02-16 4:15 pm Purchase | 13G | ANAPTYSBIO INC ANAB | TANG CAPITAL PARTNERS LP | 2,628,678 9.6% | 784,864 (+42.57%) | View |
2021-02-12 07:04 am Sale | 13G | ANAPTYSBIO INC ANAB | STATE STREET CORP STT | 1,215,576 4.44% | -729,433 (-37.50%) | View |
2021-02-11 4:41 pm Sale | 13G | ANAPTYSBIO INC ANAB | BIOTECHNOLOGY VALUE FUND L P | 0 0% | -1,441,565 (Position Closed) | View |
2021-02-10 10:30 am Purchase | 13G | ANAPTYSBIO INC ANAB | VANGUARD GROUP INC | 2,220,321 8.12% | 25,660 (+1.17%) | View |
2021-02-08 09:16 am Purchase | 13G | ANAPTYSBIO INC ANAB | PERCEPTIVE ADVISORS LLC | 1,495,336 5.5% | 1,495,336 (New Position) | View |
2021-01-28 5:56 pm Sale | 13G | ANAPTYSBIO INC ANAB | BlackRock Inc. BLK | 1,907,834 7% | -140,780 (-6.87%) | View |
2021-01-14 4:59 pm Purchase | 13G | ANAPTYSBIO INC ANAB | EcoR1 Capital LLC | 3,813,324 13.9% | 1,847,224 (+93.95%) | View |
2021-01-13 5:06 pm Purchase | 13G | ANAPTYSBIO INC ANAB | Point72 Asset Management L.P. | 1,377,942 5% | 1,377,942 (New Position) | View |
2020-11-18 3:35 pm Sale | 13D | ANAPTYSBIO INC ANAB | Frazier Healthcare V LP | 1,017,595 3.7% | -1,352,706 (-57.07%) | View |
2020-04-09 2:20 pm Sale | 13G | ANAPTYSBIO INC ANAB | FEDERATED HERMES INC. FHI | 1,273,767 4.67% | -1,104,533 (-46.44%) | View |
2020-02-14 2:12 pm Purchase | 13G | ANAPTYSBIO INC ANAB | EcoR1 Capital LLC | 1,966,100 7.2% | 245,600 (+14.27%) | View |
2020-02-13 2:58 pm Purchase | 13G | ANAPTYSBIO INC ANAB | FEDERATED HERMES INC. FHI | 2,378,300 8.77% | 2,378,300 (New Position) | View |
2020-02-13 08:09 am Purchase | 13G | ANAPTYSBIO INC ANAB | STATE STREET CORP STT | 1,945,009 7.17% | 1,945,009 (New Position) | View |
2020-02-12 4:26 pm Sale | 13G | ANAPTYSBIO INC ANAB | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0% | -2,295,000 (Position Closed) | View |
2020-02-12 09:26 am Purchase | 13G | ANAPTYSBIO INC ANAB | VANGUARD GROUP INC | 2,194,661 8.08% | 305,460 (+16.17%) | View |